Abstract
Seventeen normal volunteers received either 0.5 mg, 1.5 mg, or 2.5 mg physostigmine i.v. in a placebo-drug-placebo single-blind design. EEG was recorded simultaneously and analyzed by computerized spectral analysis. Eleven healthy elderly volunteers (mean age=69.1 years) with mild memory impairment were treated with placebo, followed by oral choline chloride (either 8 g/day for 3 weeks, or 16 g/day for 1 week), and then, again, placebo. Recordings of spontaneous EEG and EEG event-related potentials (contingent negative variation) were obtained during both placebo and choline treatments. The larger doses of physostigmine produced an increase in low frequency activity and a slowing of the peak alpha frequency. Oral choline chloride had no effect on the EEG as measured by spectral analysis, but appears to have differential effects on contingent negative variation (CNV) amplitude and reaction time, depending upon the initial CNV amplitude.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Boyd, W. D., Graham-White, J., Blackwood, G., Glen, I., McQueen, J.: Clinical effects of choline in Alzheimer senile dementia. Lancet 1977II, 711
Davis, B. M., Davis, K. L., Berger, P. A.: Cholinergic effects on neuroendocrine function. Proceedings of the VIth World Congress of Psychiatry (Honolulu, Hawaii, August 1977)
Davis, K. L., Hollister, L. E., Barchas, J. D., Berger, P. A.: Choline in tardive dyskinesia and Huntington's disease. Life Sci. 19, 1507–1516 (1976a)
Davis, K. L., Hollister, L. E., Overall, J., Johnson, A., Train, K.: Physostigmine: effects on cognition and affect in normal subjects. Psychopharmacology 51, 23–27 (1976b)
Davis, K. L., Hollister, L. E., Goodwin, F. K., Gordon, E. K.: Neurotransmitter metabolites in the cerebrospinal fluid of man following physostigmine. Life Sci. 21, 933–936 (1977)
Davis, K. L., Berger, P. A., Hollister, L. E., Defraites, E.: Physostigmine in mania. Arch. Gen. Psychiatry 35, 119–122 (1978a)
Davis, K. L., Mohs, R., Tinklenberg, J. R., Pfefferbaum, A., Hollister, L. E., Kopell, B. S.: Physostigmine: improvement of long-term memory processes in normal humans. Science 201, 272–274 (1978b)
Drachman, D. A., Leavitt, J.: Human memory and the cholinergic system. Arch. Neurol. (Chicago) 30, 113–121 (1974)
Fink, M.: Quantitative electroencephalography in human psychopharmacology, II: Drug patterns. In: EEG and behavior, G. Glaser, ed., pp. 177–197. New York: Basic Books 1963
Goldstein, L., Beck, R. A.: Amplitude analysis of the electroen-cephalogram. Int. Rev. Neurobiol. 8, 265–312 (1965)
Grob, D., Harvey, A. M., Langworthy, O. R., Lilienthal, J. L., Jr.: The administration of di-isofluorophosphate (DFP) to man. III: Effect on the central nervous system with special reference to the electrical activity of the brain. Bull. Johns Hopkins Hosp. 81, 257–266 (1947)
Janowsky, D. S., El-Youself, J. K., Davis, J. M.: Parasympathetic suppression of manic symptoms by physostigmine. Arch. Gen. Psychiatry 28, 542–547 (1973)
Karczmar, A. G.: Exploitable aspects of central cholinergic functions particularly with respect to the EEG, motor, analgesic, and mental functions. In: Cholinergic mechanisms and psychopharmacology, D. Jenden, ed., pp. 679–708. New York: Plenum 1977
Kutas, M., McCarthy, G., Donchin, E.: Augmenting mental chronometry: The P300 as a measure of stimulus evaluation time. Science 197, 792–795 (1977)
Lesny, I., Votja, V.: Eserine activation of the EEG in children. Electroencephalogr. Clin. Neurophysiol. 12, 742–744 (1960)
Matousek, M.: Frequency and correlation analysis. In: Part A of Handbook of electroencephalography and clinical neurophysiology, vol. 5, A. Remond, ed., Evaluation of bioelectrical data from brain, nerve, and muscle, Sect. II, M. A. B. Brazier, D. A. Walker, eds., pp. 61–66 Amsterdam: Elsevier 1973
Mohs, R. C., Davis, K. L., Tinklenberg, J. R., Hollister, L. E., Yesavage, J. A., Kopell, B. S.: Choline chloride treatment of memory deficits in the elderly. Am. J. Psychiatry (in press)
Pfefferbaum, A., Roth, W. T., Kopell, B. S.: State-trait considerations of event-related potential markers of psychopathology. Psychopharmacol. Bull. 15, 36–39 (1979)
Pfeiffer, C. A., Goldstein, L., Munoz, C., Murphree, H. B., Jenny, E. J.: Quantitative comparisons of the electroencephalographic stimulant effects of deanol, choline, and amphetamine. Clin. Pharmacol. Ther. 4, 461–466 (1963)
Reiger, H., Okonek, S.: The EEG in alkylphosphate poisoning (anticholinesterase insecticides). Electroencephalogr. Clin. Neurophysiol. 39, 555 (1975)
Romano, J., Engel, G. L.: Studies of delirium. I. Electroencephalographic data. Arch. Neurol. Psychiatry 51, 356–362 (1944)
Roth, W. T., Tinklenberg, J. R., Kopell, B. S.: Ethanol and marijuana effects on event-related potentials in a memory retrieval paradigm. Electroencephalogr. Clin. Neurophysiol. 42, 381–388 (1977)
Rowntree, D. W., Nevin, S., Wilson, A.: The effects of di-isofluorophosphonate in schizophrenia and manic depressive psychosis. J. Neurol. Neurosurg. Psychiatry 13, 47–59 (1950)
Sitaram, M., Wyatt, R. J., Dawson, S., Gillin, J. C.: REM sleep induction by physostigmine during sleep. Science 191, 1281–1282 (1976)
Tecce, J. J.: Contingent negative variation and individual differences. Arch. Gen. Psychiatry 24, 1–15 (1971)
Tecce, J. J.: Contingent negative variation (CNV) and psychological processes in man. Psychol. Bull. 77, 73–106 (1972)
Van Meter, W. G., Karczmar, A. G.: An effect of physostigmine on the central nervous system of rabbits, related to brain levels of norepinephrine. Neuropharmacology 10, 379–390 (1971)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pfefferbaum, A., Davis, K.L., Coulter, C.L. et al. EEG effects of physostigmine and choline chloride in humans. Psychopharmacology 62, 225–233 (1979). https://doi.org/10.1007/BF00431952
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00431952